TABLE IV.
PACCI known-groups validity: trend in mean PACCI (95% CI) sum score and problem index values across clinician rating of asthma disease status using ANOVA
| Clinician rating of asthma disease status | P value | ||||
|---|---|---|---|---|---|
| Mild intermittent (n = 132) |
Mild persistent (n = 81) |
Moderate persistent (n = 82) |
Severe persistent (n = 21) |
||
| Mean PACCI sum score | |||||
| English* (n = 264) | 2.1 (1.5–2.6) | 5.2 (4.3–6.1) | 6.6 (5.6–7.7) | 8.4 (6.2–10.6) | <.0001 |
| <5 y (n = 75) | 2.6 (1.6–3.5) | 5 (3.5–6.5) | 6 (3.8–8.2) | 9† | .001 |
| 5–11 y (n = 119) | 1.7 (0.9–2.5) | 5.3 (3.7–6.9) | 7 (5.3–8.7) | 9.8 (6.8–12.7) | <.0001 |
| ≥12 y (n = 70) | 1.9 (0.7–3.1) | 5.4 (3.6–7.1) | 6.5 (4.3–8.6) | 5.5 (1.3–9.7) | .0008 |
| African American (n = 134) | 2.4 (1.5–3.3) | 5.7 (4.4–7.1) | 7.1 (5.6–8.6) | 8.1 (5.8–10.5) | <.0001 |
| White (n = 98) | 1.5 (0.9–2.1) | 5 (3.4–6.6) | 5.9 (3.9–7.8) | 12.5 (0–31.6) | <.0001 |
| Spanish (n = 52) | 2.4 (1.2–3.7) | 2.9 (0.7–5.1) | 4.5 (3.0–6.0) | 7.6 (4.3–11.0) | .001 |
| Mean PACCI problem index | |||||
| English* (n = 259) | 0.8 (0.5–1) | 2.1 (1.7–2.5) | 2.6 (2.1–3) | 3.3 (2.3–4.2) | <.0001 |
| <5 y (n = 73) | 1 (0.6–1.4) | 2.1 (1.3–2.8) | 2.3 (1.1–3.5) | 3† | .01 |
| 5–11 y (n = 117) | 0.6 (0.3–0.9) | 2.2 (1.5–2.9) | 2.6 (2–3.3) | 3.9 (2.7–5) | <.0001 |
| ≥12 y (n = 69) | 0.7 (0.2–1.2) | 2 (1.2–2.9) | 2.6 (1.8–3.4) | 2.3 (0–5) | .002 |
| African American (n = 131) | 0.9 (0.5–1.3) | 2.4 (1.8–3) | 2.7 (2.1–3.3) | 3.4 (2.4–4.4) | <.0001 |
| White (n = 96) | 0.6 (0.3–0.8) | 1.9 (1.2–2.6) | 2.3 (1.4–3.2) | 4.5 (0–10.9) | <.0001 |
| Spanish (n = 52) | 0.7 (0.1–1.3) | 1.1 (0.1–2.1) | 1.6 (0.8–2.3) | 3.3 (1.9–4.6) | .001 |
*
Includes both English- and Spanish-speaking patients who performed spirometry.
†
No CI is presented because there is only 1 patient in this category.